# A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)

> **NCT00692913** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 515 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** FOSAVANCE 5600 (Alendronate Sodium (+) cholecalciferol)
- **DIETARY_SUPPLEMENT:** Calcium Supplement 500 mg
- **OTHER:** Referred-Care Model

## Key facts

- **NCT ID:** NCT00692913
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 515 (ACTUAL)
- **Last updated:** 2024-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692913, "A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00692913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*